Identification of NSAID Users at Risk for Gastrointestinal Complications Merel M. TielemansTies EikendalMartijn G. H. van Oijen Review Article 21 November 2012 Pages: 443 - 453
Benefit-Risk Assessment of Becaplermin in the Treatment of Diabetic Foot Ulcers DrNikolaos PapanasEfstratios Maltezos Review Article 21 November 2012 Pages: 455 - 461
A Decade of Safety-Related Regulatory Action in the Netherlands Peter G.M. MolSabine M. J. M. StrausFlora M. Haaijer-Ruskamp Original Research Article 21 November 2012 Pages: 463 - 474
Validation of Statistical Signal Detection Procedures in EudraVigilance Post-Authorization Data Yolanda AlvarezAna HidalgoJim Slattery Original Research Article 21 November 2012 Pages: 475 - 487
Infliximab Paediatric Crohn’s Disease Educational Plan Alejandro AranaSam AllenFelix M. Arellano Original Research Article 21 November 2012 Pages: 489 - 501
Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™ Ayako SuzukiRaul J. AndradeJames W. Freston Original Research Article 21 November 2012 Pages: 503 - 522
Leflunomide in Combination Therapy for Rheumatoid Arthritis Ruth L. Savage Commentary 21 November 2012 Pages: 523 - 526